Skip to Main Content

Paper Details

Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants.
Cell Reports
11
2022
-, BA.2, BA.2.12, BA.4, Beta variant, NA8, NE12, SARS, SARS-CoV, SARS-CoV-2, human
Author NameAffiliation
Yaroslav TsybovskyInc., Frederick National Laboratory for Cancer Research
Baoshan ZhangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • 1 - 3

Datasets

Release 1.2